Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction

Background. Inflammation is a critical factor in the development and progression of myocardial infarction and cardiac fibrosis. Thymosin β4 (Tβ4) alleviates the disease process via protective antioxidant and anti-inflammatory mechanisms. Although Tβ4 has been shown to have a protective effect in myo...

Full description

Saved in:
Bibliographic Details
Main Authors: Fei Wang, Yajuan He, Naijuan Yao, Litao Ruan, Zhen Tian
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Cardiovascular Therapeutics
Online Access:http://dx.doi.org/10.1155/2022/1308651
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565820163620864
author Fei Wang
Yajuan He
Naijuan Yao
Litao Ruan
Zhen Tian
author_facet Fei Wang
Yajuan He
Naijuan Yao
Litao Ruan
Zhen Tian
author_sort Fei Wang
collection DOAJ
description Background. Inflammation is a critical factor in the development and progression of myocardial infarction and cardiac fibrosis. Thymosin β4 (Tβ4) alleviates the disease process via protective antioxidant and anti-inflammatory mechanisms. Although Tβ4 has been shown to have a protective effect in myocardial infarction, its impact on cardiac fibrosis has not been well reported. In this study, we evaluated the influence of exogenous Tβ4 on myocardial infarction and cardiac fibrosis and explored the possible underlying mechanism. Methods. Real-time quantitative reverse-transcription PCR (qRT-PCR), immunohistochemistry (IHC), and Western blot were used to analyze Tβ4 expression in acute myocardial infarction (AMI) cardiac tissues. The effects of intraperitoneal adeno-associated virus-Tβ4 (AAV-Tβ4) on ligation-induced AMI in mice were studied using cardiac function parameters, and RT-PCR, Western blot, HE staining, Masson staining, and IHC were used to assess the degree of myocardial fibrosis. The effects of Tβ4 were confirmed in vitro using mouse cardiac myocytes and myofibroblasts. Results. Tβ4 was shown to be significantly elevated in mice AMI cardiac tissues. In mice, AAV-Tβ4 induced exogenous expression of Tβ4 significantly reduced oxidative damage, inflammation, cardiac dysfunction, and fibrosis. H2O2 inhibited mitophagy and increased inflammation in mouse cardiac myocytes via oxidative stress, and Tβ4 substantially reduced mitophagy inhibition and inflammasome activation in myocytes caused by H2O2. Furthermore, Tβ4 decreased cardiac myofibroblast growth and reduced TGF-β1-induced activation. Conclusions. AAV-Tβ4 induced expression of Tβ4 reduced inflammation, heart damage, and eventual fibrosis in vivo. Tβ4 helped to reduce oxidative stress, promote mitophagy, and alleviate inflammation and fibrosis. Exogenous supplementation of Tβ4 might be a promising therapeutic agent for treating myocardial infarction as well as cardiac fibrosis.
format Article
id doaj-art-d96ad24e35fd4d7e9eecf8e012317fe8
institution Kabale University
issn 1755-5922
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Cardiovascular Therapeutics
spelling doaj-art-d96ad24e35fd4d7e9eecf8e012317fe82025-02-03T01:06:38ZengWileyCardiovascular Therapeutics1755-59222022-01-01202210.1155/2022/1308651Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial InfarctionFei Wang0Yajuan He1Naijuan Yao2Litao Ruan3Zhen Tian4Department of UltrasoundDepartment of UltrasoundDepartment of Infectious DiseasesDepartment of UltrasoundDepartment of UltrasoundBackground. Inflammation is a critical factor in the development and progression of myocardial infarction and cardiac fibrosis. Thymosin β4 (Tβ4) alleviates the disease process via protective antioxidant and anti-inflammatory mechanisms. Although Tβ4 has been shown to have a protective effect in myocardial infarction, its impact on cardiac fibrosis has not been well reported. In this study, we evaluated the influence of exogenous Tβ4 on myocardial infarction and cardiac fibrosis and explored the possible underlying mechanism. Methods. Real-time quantitative reverse-transcription PCR (qRT-PCR), immunohistochemistry (IHC), and Western blot were used to analyze Tβ4 expression in acute myocardial infarction (AMI) cardiac tissues. The effects of intraperitoneal adeno-associated virus-Tβ4 (AAV-Tβ4) on ligation-induced AMI in mice were studied using cardiac function parameters, and RT-PCR, Western blot, HE staining, Masson staining, and IHC were used to assess the degree of myocardial fibrosis. The effects of Tβ4 were confirmed in vitro using mouse cardiac myocytes and myofibroblasts. Results. Tβ4 was shown to be significantly elevated in mice AMI cardiac tissues. In mice, AAV-Tβ4 induced exogenous expression of Tβ4 significantly reduced oxidative damage, inflammation, cardiac dysfunction, and fibrosis. H2O2 inhibited mitophagy and increased inflammation in mouse cardiac myocytes via oxidative stress, and Tβ4 substantially reduced mitophagy inhibition and inflammasome activation in myocytes caused by H2O2. Furthermore, Tβ4 decreased cardiac myofibroblast growth and reduced TGF-β1-induced activation. Conclusions. AAV-Tβ4 induced expression of Tβ4 reduced inflammation, heart damage, and eventual fibrosis in vivo. Tβ4 helped to reduce oxidative stress, promote mitophagy, and alleviate inflammation and fibrosis. Exogenous supplementation of Tβ4 might be a promising therapeutic agent for treating myocardial infarction as well as cardiac fibrosis.http://dx.doi.org/10.1155/2022/1308651
spellingShingle Fei Wang
Yajuan He
Naijuan Yao
Litao Ruan
Zhen Tian
Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction
Cardiovascular Therapeutics
title Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction
title_full Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction
title_fullStr Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction
title_full_unstemmed Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction
title_short Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction
title_sort thymosin β4 protects against cardiac damage and subsequent cardiac fibrosis in mice with myocardial infarction
url http://dx.doi.org/10.1155/2022/1308651
work_keys_str_mv AT feiwang thymosinb4protectsagainstcardiacdamageandsubsequentcardiacfibrosisinmicewithmyocardialinfarction
AT yajuanhe thymosinb4protectsagainstcardiacdamageandsubsequentcardiacfibrosisinmicewithmyocardialinfarction
AT naijuanyao thymosinb4protectsagainstcardiacdamageandsubsequentcardiacfibrosisinmicewithmyocardialinfarction
AT litaoruan thymosinb4protectsagainstcardiacdamageandsubsequentcardiacfibrosisinmicewithmyocardialinfarction
AT zhentian thymosinb4protectsagainstcardiacdamageandsubsequentcardiacfibrosisinmicewithmyocardialinfarction